Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.61 |
| ▸ | DPP4 | P27487 | 5/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.48 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.48 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.48 |
| ▸ | FAP | Q12884 | 2/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | ARG1 | P05089 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 2/20 | 0.47 |
| ▸ | TACR1 | P25103 | 1/20 | 0.46 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | PLAUR | Q03405 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376037 | 1.00 | HDAC8 (0.61) | HDAC8DPP4ALPIPKMPTGS1 | |
| SCHEMBL3142017 | 0.84 | HDAC8 (0.66) | HDAC8DPP4ALPIPKMPTGS1 | |
| SCHEMBL7835478 | 0.84 | HDAC8 (0.66) | HDAC8DPP4ALPIPKMPTGS1 | |
| SCHEMBL6052908 | 0.84 | HDAC8 (0.66) | HDAC8DPP4ALPIPKMPTGS1 | |
| SCHEMBL27545467 | 0.84 | HDAC8 (0.66) | HDAC8DPP4ALPIPKMPTGS1 | |
| SCHEMBL6052777 | 0.84 | HDAC8 (0.66) | HDAC8DPP4ALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL6626949 | 0.82 | HDAC8 (0.67) | HDAC8DPP4ALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL6162896 | 0.82 | HDAC8 (0.67) | HDAC8DPP4ALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL6625415 | 0.82 | HDAC8 (0.67) | HDAC8DPP4ALPIPKMPTGS1 | |
| Hydrochloric Acid SCHEMBL6163613 | 0.82 | HDAC8 (0.67) | HDAC8DPP4ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224210-A1 | NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS | ACTELION PHARMACEUTICALS LTD. (CH) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224210-A1 | NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS | CTSA, BECN1, HDAC6 | HDAC8 16/4885DPP4 754/4885ALPI 2815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.